Your browser doesn't support javascript.
loading
Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.
Xu, Xiaowei; Yu, Rui; Xiao, Lanlan; Wang, Jie; Yu, Meihong; Xu, Junjie; Tan, Yajun; Ma, Xiao; Wu, Xiaoxin; Lian, Jiangshan; Huang, Kaizhou; Ouyang, Xiaoxi; Bi, Sheng; Wu, Shipo; Wang, Xiaoyan; Jin, Jiandi; Yu, Ling; Zhang, Huafen; Wei, Qi; Shi, Jinfa; Chen, Wei; Li, Lanjuan.
Affiliation
  • Xu X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Yu R; Beijing Institute of Biotechnology, Beijing, 100071, China.
  • Xiao L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Wang J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Yu M; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Xu J; Beijing Institute of Biotechnology, Beijing, 100071, China.
  • Tan Y; National Institutes for Food and Drug Control, Beijing, 102629, China.
  • Ma X; National Institutes for Food and Drug Control, Beijing, 102629, China.
  • Wu X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Lian J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Huang K; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Ouyang X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Bi S; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Wu S; Beijing Institute of Biotechnology, Beijing, 100071, China.
  • Wang X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Jin J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Yu L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Zhang H; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
  • Wei Q; Sichuan Zihao Times Pharmaceutical Co., Ltd, Meishan, Sichuan Province, 610000, China.
  • Shi J; Sichuan Zihao Times Pharmaceutical Co., Ltd, Meishan, Sichuan Province, 610000, China.
  • Chen W; Beijing Institute of Biotechnology, Beijing, 100071, China.
  • Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 31000
Adv Sci (Weinh) ; 8(15): e2002751, 2021 08.
Article in En | MEDLINE | ID: mdl-34081408
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus / Tetanus Toxoid / Immunogenicity, Vaccine Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Adv Sci (Weinh) Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus / Tetanus Toxoid / Immunogenicity, Vaccine Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Adv Sci (Weinh) Year: 2021 Document type: Article